Continued here:
Artelo Biosciences Files Patent on Use of Fatty Acid Binding Protein 5 Inhibitors for Treating Psychological Disorders
Kinnate Biopharma Inc. to Participate at the Goldman Sachs 42nd Annual Global Healthcare Conference
atai Life Sciences to Participate in Upcoming November Investor Conferences
Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis B
Motus GI Announces Warrant Exercise Agreement Resulting in Expected Gross Proceeds to the Company of up to $11 Million
Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase 1/2 Trial of AXO-AAV-GM1 for GM1 Gangliosidosis
Arch Biopartners Receives Government of Canada Funding to Support Phase II Therapeutic Trial of Metablok for COVID-19
Timber Pharmaceuticals Signs Waiver Agreement with Warrant Holders
Here is the original post:
Timber Pharmaceuticals Signs Waiver Agreement with Warrant Holders
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China
500 mg/dL)]]>
Read the rest here:
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China
Chinook Therapeutics to Present at Upcoming Investor Conferences
Capricor Therapeutics to Present Third Quarter 2020 Financial Results and Recent Corporate Update on November 12
Immutep Announces Expansion of TACTI-002 Collaboration Trial
Notice of Extraordinary General Meeting in Immunicum AB (publ)
Continue reading here:
Notice of Extraordinary General Meeting in Immunicum AB (publ)
Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Marrone Bio Innovations Appoints Lara L. Lee to Board of Directors
Read the original here:
Marrone Bio Innovations Appoints Lara L. Lee to Board of Directors
Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders
Read the original here:
Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection
See original here:
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection